Question of the Day: A Learning Success (S10.001)

Abstract

<h3>Objective:</h3> To demonstrate the successful implementation of the American Academy of Neurology (AAN) Question of the Day (QOD) mobile application and its value to AAN members. <h3>Background:</h3> QOD, launched in 2020, provides daily board exam–style multiple-choice questions in two tracks: one for practicing neurologists and one for medical students. Questions for neurologists follow a yearly curriculum based on the American Board of Psychiatry and Neurology (ABPN) Maintenance of Certification (MOC) content outline. Topics include a wide variety of neurology subspecialties. Each question is accompanied by a detailed rationale and current references, many of which are hyperlinked to peer-reviewed resources. Users can earn up to 29 self-assessment continuing medical education (SA-CME) per year, which is 2 SA-CME per 25 QOD questions. The ABPN has approved QOD as part of a comprehensive lifelong learning program. <h3>Design/Methods:</h3> Data collected from QOD since April 2021 include activity by AAN member type, total active daily users, number of CME earned, and program evaluation data. <h3>Results:</h3> Total users per year were 5.6K, 9.5K, and 11K for 2020, 2021, and 2022, respectively, with practicing neurologists (25%) and junior (59%) AAN members the most engaged, and with participation from 123 countries. Average daily users increased from 1.4K in 2021 to 1.5K in 2022, with weekly (2.7K) and monthly (4.3K) usage comparable in 2021 and 2022. In total, 8.7K hours of SA-CME have been claimed in 2022 compared with 5.8K in 2021. Satisfaction has remained high since launch and is currently 99%. Users report that the questions are useful, fair, balanced, and of high quality. <h3>Conclusions:</h3> Since its introduction in 2020, QOD has become a very popular, effective continuing education program for AAN members. There has been substantial growth of new users each year while maintaining a strong contingency of daily users. <b>Disclosure:</b> Dr. Seachrist has received personal compensation for serving as an employee of American Academy of Neurology. The institution of Dr. Seachrist has received research support from Bristol Myers Squibb. Dr. Seachrist has a non-compensated relationship as a Topic Group Member with American Academy of Neurology that is relevant to AAN interests or activities. Ms. Shindoll has nothing to disclose. The institution of Dr. Pawar has received research support from ACGME "Back to Bedside" Grant support. Dr. London has nothing to disclose. Dr. Khan has nothing to disclose. The institution of Dr. Kraakevik has received research support from Parkinson Foundation. Dr. Graber has a non-compensated relationship as a Editorial Board member with Neuro-Oncology: Practice, published by Oxford that is relevant to AAN interests or activities. Dr. Graber has a non-compensated relationship as a Editorial Board Member with Journal of Pain and Symptom Management that is relevant to AAN interests or activities. Dr. Graber has a non-compensated relationship as a Board of Directors with American Society of Neuroimaging that is relevant to AAN interests or activities. Dr. Graber has a non-compensated relationship as a Certification Exam Committee Member with United Council of Neurogical Subspecialties that is relevant to AAN interests or activities. Dr. Graber has a non-compensated relationship as a Question of the Day ’app’ committee with American Academy of Neurology that is relevant to AAN interests or activities. Dr. Graber has a non-compensated relationship as a Editorial Board Member with Practical Neurology (BMC) that is relevant to AAN interests or activities. Dr. Gliksman has nothing to disclose.